Fear of cancer recurrence and hope level in patients receiving surgery for non-small cell lung cancer: a study on the mediating role of social support

被引:28
|
作者
Liu, Man [1 ]
Liu, Lu [1 ]
Zhang, Shuoning [1 ]
Li, Ting [2 ]
Ma, Fengyan [1 ]
Liu, Yan [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Dept Thorac Surg, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R China
[2] Ctr Hunan Prov Hlth Commiss, Talent Anxiety Serv, Changsha, Peoples R China
关键词
Non-small cell lung cancer (NSCLC); Surgery; Fear of cancer recurrence (FCR); Hope level; Social support; SEX-DIFFERENCES; INTERVENTION; FEATURES; STRESS; CARE;
D O I
10.1007/s00520-022-07318-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose To study the level of fear of cancer recurrence (FCR) in patients receiving surgery for non-small cell lung cancer (NSCLC) and explore related factors that can increase levels of hope in this population, enhance the confidence to defeat the disease, and thus increase the quality of life. Methods A total of 327 postoperative NSCLC patients from the National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College were enrolled. All participants completed the General Questionnaire, Fear of Progression Questionnaire-Short Form (FoP-Q-SF), Herth Hope Index (HHI) Scale, and Social Support Rating Scale (SSRS). Results The mean FoP-Q-SF score was (30.3 +/- 9.48) points in postoperative NSCLC patients, Among them, there were 188 patients (57.5%) who had psychological dysfunction, indicated by a score of > l = 34. Patient sex and family income were independent risk factors for FCR (both p < 0.05). Correlation analysis revealed a negative association between FCR and hope level (p < 0.05) and a positive association between hope level and social support (p < 0.05). Notably, social support mediated the association between FCR and hope in patients receiving surgery for NSCLC (contribution effect: 30.24%). Conclusion Postoperative NSCLC patients experience a moderate level of FCR, especially females and those with a low family income. Social support partially mediates the relationship between FCR and hope in this population. Therefore, an increase in the level of social support can increase hope among these patients and advancing recovery.
引用
收藏
页码:9453 / 9460
页数:8
相关论文
共 50 条
  • [41] Role of artemin in non-small cell lung cancer
    Song, Zuoqing
    Yang, Fan
    Du, Hui
    Li, Xin
    Liu, Jinghao
    Dong, Ming
    Xu, Xiaohong
    [J]. THORACIC CANCER, 2018, 9 (05) : 555 - 562
  • [42] The role of radiotherapy in non-small cell lung cancer
    Sause, WT
    [J]. CHEST, 1999, 116 (06) : 504S - 508S
  • [43] The role of KSRP in non-small cell lung cancer
    Wilson, Lora A.
    Winn, Robert A.
    [J]. CANCER RESEARCH, 2011, 71
  • [44] The role of chemotherapy in non-small cell lung cancer
    Deschamps, C
    [J]. XXX WORLD CONGRESS OF THE INTERNATIONAL COLLEGE OF SURGEONS, VOLS 1-2, 1996, : 923 - 926
  • [45] The Role of Autophagia in Non-Small Cell Lung Cancer
    Sever, Ozlem N.
    Demir, Gokhan
    [J]. UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2017, 27 (03): : 185 - 192
  • [46] Is there a role for cetuximab in non-small cell lung cancer?
    Morgensztern, Daniel
    Govindan, Ramaswamy
    [J]. CLINICAL CANCER RESEARCH, 2007, 13 (15) : 4602S - 4605S
  • [47] Role of pemetrexed in non-small cell lung cancer
    Longo-Sorbello, Giuseppe S. A.
    Chen, Bobin
    Budak-Alpdogan, Tulin
    Bertino, Joseph R.
    [J]. CANCER INVESTIGATION, 2007, 25 (01) : 59 - 66
  • [48] Recurrence and Risk Factors for Relapse in Patients with Non-Small Cell Lung Cancer Treated by Surgery with Curative Intent
    Cruz, Cristiana
    Afonso, Margarida
    Oliveiros, Barbara
    Pego, Alice
    [J]. ONCOLOGY, 2017, 92 (06) : 347 - 352
  • [49] Vitamin supplementation in patients receiving pemetrexed for advanced non-small cell lung cancer
    de Marinis, Filippo
    Passaro, Antonio
    Clarke, Stephen
    [J]. LUNG CANCER, 2013, 82 (03) : 511 - 511
  • [50] Addition of metformin for non-small cell lung cancer patients receiving antineoplastic agents
    Wang, Yan
    Hu, Yuanyuan
    Wang, Ting
    Che, Guowei
    Li, Lu
    [J]. FRONTIERS IN PHARMACOLOGY, 2023, 14